CDC Adds Type 1 Diabetes to Covid-19 Vaccine List
The CDC (Centers for Disease Control and Prevention) maintains a list people eligible for the COVID-19 vaccine called, “People with Certain Medical Conditions” and they’ve just added people living with type 1 diabetes.
Read more here on the CDC website.
Dexcom G6 App Update
Dexcom BGs right on your iPhone home screen with widgets
Know the Signs and Symptoms of Type 1 Diabetes/Conozca los síntomas de la Diabetes Typo Uno
Know the Signs and Symptoms of Type 1 Diabetes
Contact a physician immediately when symptoms are present
Frequent/Excessive urination
Unquenchable Thirst
Unexplained/Rapid weight loss
Nausea, Vomiting
Metallic or Fruity Smelling Breath
Bed-wetting
Extreme hunger
Mood changes/swings, irritability
Fatigue and weakness
Blurred vision, headache
Panting, Heavy Breathing
Press play to hear the sign and symptoms in English and Español
Conozca los síntomas de la Diabetes Typo Uno
Micción Frecuente / Orina Excesiva
Sed Insaciable
Bajo De Peso Rápido E Inexplicable
Náusea/ Vomitó
Aliento Metálico/ Frutado
Mojando La Cama
Hambre Extrema
Cambios De Humor De Repente O Irritabilidad
Fatiga Y Debilidad
Visión Borrosa, Dolores De Cabeza
Jadeó, Respirando Fuerte
Thank you to Paola Marrero for her beautiful translation
click to enlarge/share
click to enlarge/share
Dexcom G6 Covered 100% for Veterans
Dexcom G6 Continuous Glucose Monitoring System Now Available at Veterans Affairs Pharmacies Across the United States
New government contract and pharmacy availability improves access to Dexcom G6 continuous glucose monitoring for hundreds of thousands of veterans with diabetes
Prescribing Dexcom G6 is now more cost effective and efficient for the VA than the previous procurement pathway
The cost of Dexcom CGM is 100% covered by the VA for patients with Type 1 or Type 2 diabetes who meet eligibility criteria
To be eligible for Dexcom G6 coverage under Veterans Affairs, a healthcare provider must verify that the patient meets the following qualifying criteria:
Has diabetes
Performs frequent blood glucose monitoring (BGM) testing (≥4x/day)
Takes ≥3 daily injections of insulin or uses an insulin pump
Has the skillset and knowledge to use CGM successfully
Has agreed to follow up in the clinic a minimum of every 6 months
And, is one or more of the following:
At risk for hypoglycemia
Unable to meet glycemic control, despite adherence to the treatment regimen
Performs job-related activities where a hypoglycemic event could put them at risk of harm
Unable to perform self-monitoring of blood glucose due to disability or disease
Interested Veterans can get started here
New technique efficiently converts human stem cells into insulin-producing cells
Researchers have converted human stem cells into insulin-producing cells and demonstrated in mice infused with such cells that blood sugar levels can be controlled and diabetes functionally cured for nine months.
The findings, from researchers at Washington University School of Medicine in St. Louis, are published online Feb. 24 in the journal Nature Biotechnology.
“These mice had very severe diabetes with blood sugar readings of more than 500 milligrams per deciliter of blood — levels that could be fatal for a person — and when we gave the mice the insulin-secreting cells, within two weeks their blood glucose levels had returned to normal and stayed that way for many months,” said principal investigator Jeffrey R. Millman, PhD, an assistant professor of medicine and of biomedical engineering at Washington University.
Check out the rest of this article here
Listen to Dr. Millman on episode 382 of the Juicebox Podcast